Filing Details
- Accession Number:
- 0001181431-12-035283
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-06-07 18:14:57
- Reporting Period:
- 2012-06-06
- Filing Date:
- 2012-06-07
- Accepted Time:
- 2012-06-07 18:14:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
787253 | Natural Alternatives International Inc | NAII | Medicinal Chemicals & Botanical Products (2833) | 841007839 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1115556 | A Mark Ledoux | 1185 Linda Vista Dr San Marcos CA 92078 | Ceo/Chairman | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-06-06 | 10,000 | $6.74 | 185,037 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-06-07 | 2,000 | $0.00 | 183,037 | No | 4 | G | Direct | |
Common Stock | Disposition | 2012-06-06 | 20,000 | $6.74 | 557,851 | No | 4 | S | Indirect | By LeDoux Family Limited Partnership |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | G | Direct | |
No | 4 | S | Indirect | By LeDoux Family Limited Partnership |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 41,416 | Indirect | By IRA |
Common Stock | 7,200 | Indirect | By Self as Custodian for Marcelle Jeannette LeDoux |
Common Stock | 800 | Indirect | By Self as Custodian for Jean-Marc Emile LeDoux |
Common Stock | 28,000 | Indirect | By 401(K) |
Common Stock | 36,677 | Indirect | By Self as Trustee for the LeDoux Family Trust U/D/T December 21, 1992 |
Footnotes
- This transaction represents a repurchase of common stock by the Company in a private transaction. The repurchase was approved by the Audit Committee and the independent members of the Company's Board of Directors on May 25, 2012.
- The approval of the Company's Audit Committee and Board of Directors was conditioned on a purchase price equal to 90% of the closing price of the Company's common stock as reported by Nasdaq on June 1, 2012, which date represented the third day after the filing by the Company of a Current Report on Form 8-K reporting the approval of the repurchase. The closing price on June 1, 2012 as reported by Nasdaq was $7.49.
- This transaction represents a donation of the shares to a private institution.